Stream Your Event | Partners | Speakers CART ITEMS: - | CHECKOUT

or Log In

(recommended)

Share your favorite videos with friends
Comment on videos and join the conversation
Get personalized recommendations
Enjoy exclusive offers

Purchased a FORA.tv video on another website? Login here with the temporary account credentials included in your receipt.

Username or Email:
Password:
Forgot your password? Keep me logged in

business
environment
politics
science
technology
culture

Preview

When I'm 164: If Anti-Aging Science Succeeds, Then What?

Watch Full Video | previews

Litquake

Likes

Dislikes

RATE

Info
Bio
Chapters
Preview
Download
Zoom In

Partner:: Litquake
Location:: SF Writer's Grotto
San Francisco, CA
Event Date:: 10.10.12
Speakers:: Sonia Arrison,; David Ewing Duncan,; Paul Saffo
Tags:: aging

Summary: As part of San Francisco Litquake festival, Sonia Arrison, author of 100 Plus, David Ewing Duncan, writer of When I'm 164, join the great futurist Paul Saffo to discuss what happens to humans if the science of anti-aging succeeds.

Bio

Sonia Arrison

Sonia Arrison is a technology analyst and bestselling author of 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith. She is a founder and trustee of Singularity University.

David Ewing Duncan

David Ewing Duncan is an award-winning, best-selling author of eight books published in 21 languages. He is a founder and co-curator of Arc Programs. David is a columnist for Newsweek, a correspondent for The Atlantic and the chief correspondent for NPR Talk’s Biotech Nation. David writes for The New York Times, Fortune, Wired, National Geographic, Discover and many other publications. He is a former commentator for NPR’s Morning Edition and a special correspondent and producer for ABC’s Nightline and 20/20, and correspondent for NOVA’s ScienceNow!. His latest book is When I’m 164: The new science of radical life extension, and what happens if it succeeds. He also wrote Experimental Man: What One Man’s Body Reveals about His Future, Your Health, and Our Toxic World (Wiley). He was the founder and director of the BioAgenda Institute, and the founding director of the Center of Life Science Policy at UC Berkeley. David is finishing his first novel, a biomedical thriller. David’s work has won numerous awards, including Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing. David lives in San Francisco and is a member of the SF Writer’s Grotto. His website is www.davidewingduncan.com.

Paul Saffo

Paul Saffo is a forecaster with over two decades experience exploring the dynamics of large-scale, long-term change. He is Managing Director of Foresight at Discern Analytics, teaches at Stanford University and is a researcher through mediaX at Stanford University. Saffo serves on a variety of not-for-profit boards including the Long Now Foundation, and the Bay Area Council Economic Institute. Saffo’s essays have appeared in a wide range of publications including The Harvard Business Review, Fortune, Wired, The Los Angeles Times, Newsweek, The New York Times, and the Washington Post. Saffo holds degrees from Harvard College, Cambridge University and Stanford University.

Chapters

: Watch Full Program

01 hr 09 min 43 sec

Add to Profile
01.: David Ewing Duncan: How Long Do You Want to Live?

04 min 32 sec

Add to Profile
02.: Sonia Arrison: Bioengineering and Longevity

06 min 54 sec

Add to Profile
03.: Paul Saffo: Longevity Is Not Democratic

07 min 37 sec

Add to Profile
04.: Why Live Longer?

02 min 26 sec

Add to Profile
05.: The Science of Living Longer

07 min 24 sec

Add to Profile
06.: Technology as a Vehicle to Extend Life

05 min 11 sec

Add to Profile
07.: Longevity In Literature

05 min 59 sec

Add to Profile
08.: Upsides and Downsides to a Longer-Lived Humanity

05 min 48 sec

Add to Profile
09.: Longer Lives, Lower BIrthrates: The Coming Demographic Shift

09 min 03 sec

Add to Profile
10.: Audience Q&A

00 min 13 sec

Add to Profile
11.: Q1: Life In a Death-phobic Society

02 min 58 sec

Add to Profile
12.: Q2: Death and Religion

01 min 29 sec

Add to Profile
13.: Q3: What About Cancer?

02 min 42 sec

Add to Profile
14.: Q4: Funding Research on Aging

03 min 40 sec

Add to Profile
15.: Q5: Making Way for Future Generations

01 min 14 sec

Add to Profile
16.: Q6: Fears of Being Aged vs Fears of Being Old

00 min 37 sec

Add to Profile
17.: Final Thoughts

01 min 48 sec

Add to Profile
: Watch Full Program

01 hr 09 min 43 sec

Add to Profile

David Ewing Duncan: Why Would Anyone Want to be 150?

01 min 41 sec

Add to Profile

David Ewing Duncan, author of When I'm 164, questions the benefits of living to an advanced age. Despite medical advancement that promise greater expectancy and wellness, Duncan shares that many seniors do not wish to live to extreme ages.
Paul Saffo: What If Jobs and Einstein Lived to be 150?

02 min 53 sec

Add to Profile

Technology forecaster Paul Saffo ponders whether advancements in science and medicine would compel society to lengthen the lives of the world's greatest geniuses. Saffo also discusses the influence of people who bloomed later in life.
Watch Full Program

Add to Profile

Save this program for later

To download this program become a Front Row member. JOIN NOW >>

To download this program
become a Front Row member.

NO ADS + DOWNLOADS

ZOOM IN: Learn more with related books and additional materials.

Buy

When I'm 164: The New Science of Radical Life Extension, and What Happens If It Succeeds (Kindle Single) (TED Books)
Paul Saffo: Embracing Uncertainty: The Secret to Effective Forecasting
100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith